Searchable abstracts of presentations at key conferences in endocrinology

ea0011p409 | Diabetes, metabolism and cardiovascular | ECE2006

Lipoprotein Lp(a) in patients with systemic lupus erythematosus

Athanassiou P , Kostoglou-Athanassiou I , Kordalis A , Kalogirou Th , Galanaki Ch , Bastakis E , Kaldrymidis Ph

Systemic lupus erythematosus (SLE) is a multifactorial multisystem autoimmune disorder. Although the survival of SLE patients has been improved with the administration of immunomodulatory therapy, patients seem to suffer from complications of the disease such as atherosclerosis. Lipoprotein Lp(a) is a known risk factor for the development of atherosclerosis.The aim was to evaluate lipoprotein Lp(a) and its relationship with disease activity in patients w...

ea0011p412 | Diabetes, metabolism and cardiovascular | ECE2006

Lipoprotein Lp(a) in patients with rheumatoid arthritis

Athanassiou P , Kostoglou-Athanassiou I , Kordalis A , Kalogirou Th , Galanaki Ch , Bastakis E , Kaldrymidis Ph

Epidemiological studies show increased mortality in patients with rheumatoid arthritis (RA). One of the causes of death in RA patients is cardiovascular disease. Lipoprotein Lp(a) appears to be an independent risk factor for the development of cardiovascular diseases. The aim of the study was to evaluate serum lipid and lipoprotein Lp(a) levels in patients with RA.Patients with RA, n=50, aged 24–65 years and healthy controls, n=50 were...